Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Big Pharma
The EU and UK must make progress in Brexit negotiations “as soon as possible”, according to the associations that represent the European and British life sciences industry.   29 November 2017
Americas
A subsidiary of medical technology company Stryker has settled its clash over trade secrets with Zimmer, a medical device business.   29 November 2017
Asia
AstraZeneca and the Chinese Future Industry Investment Fund have partnered to establish a company focused on discovering, developing and commercialising new medicines.   28 November 2017
Big Pharma
Israel-headquartered Teva has announced a series of organisational and leadership changes as it seeks to address external pressures and internal inefficiencies.   28 November 2017
Biotechnology
The EU General Court has annulled a decision by the Community Plant Variety Office, in a dispute between a developer and distributor of sugar beet seeds and an Italy-based company.   27 November 2017
Big Pharma
MSD, known as Merck and Co in the US and Canada, announced plans to launch a life sciences discovery research facility just hours ahead of the UK government’s release of its industrial strategy.   27 November 2017
Big Pharma
The English Court of Appeal today handed down its decision in a dispute between pharmaceutical company Merck Sharp & Dohme (MSD) Corp and its German rival Merck KGaA, offering a mixed ruling.   24 November 2017
Big Pharma
The EU General Court has backed Endoceutics, a pharmaceutical company focused on women’s health, by revoking a finding that Merck KGaA had genuinely used a trademark.   23 November 2017
Big Pharma
The chief business officer of the Broad Institute of MIT and Harvard and a senior patent counsel at Novartis are just two of a number of experts who are attending the Life Sciences Patent Network Europe conference in London.   23 November 2017
Americas
Eli Lilly experienced a setback yesterday at the US Court of Appeals for the Federal Circuit when it affirmed that a patent owned by the company is invalid.   23 November 2017